前列腺穿刺后勃起功能障碍为短暂并发症:系统综述与荟萃分析
该系统综述与荟萃分析纳入9项研究,比较前列腺穿刺前后IIEF-5评分。穿刺后1个月平均IIEF-5约下降2.2分(效应量-0.43,p=0.002),3个月与6个月时与基线无差异。提示穿刺所致勃起功能下降轻微且短暂。
要点
- 穿刺后1个月IIEF-5平均约降2.2分,属轻度短暂变化
- 穿刺后3个月与6个月IIEF-5与基线无统计学差异
- 经直肠穿刺3个月亚组IIEF-5仍略低,约降1.25分
核心结论
- 前列腺穿刺会导致穿刺后1个月平均IIEF-5评分轻度、短暂下降,平均在3个月时恢复,6个月时仍维持基线水平。
研究设计与样本
- 在MEDLINE(经PubMed)、Embase(经Ovid)、Web of Science和Cochrane Library共4个数据库进行系统文献检索。
- 纳入所有年龄段、因怀疑前列腺癌接受经直肠或经会阴前列腺穿刺、且有穿刺前及穿刺后1、3或6个月IIEF-5评分的研究。
- 共纳入9项研究,其中6项考察经直肠前列腺穿刺,2项考察经会阴前列腺穿刺,1项同时考察两者。
- 采用效应量荟萃分析比较基线IIEF-5评分与穿刺后IIEF-5评分。
主要发现
- 穿刺后1个月平均IIEF-5评分约下降2.2分,效应量-0.43,p=0.002。
- 穿刺后3个月与基线无差异,效应量-0.08,p=0.52。
- 穿刺后6个月与基线无差异,效应量-0.11,p=0.18。
- 探索性亚组分析显示经直肠前列腺穿刺3个月时平均IIEF-5较基线显著降低(p=0.047),约下降1.25分。
关键数值与推荐
- 穿刺后1个月:IIEF-5平均约降2.2分,效应量-0.43,p=0.002。
- 穿刺后3个月:效应量-0.08,p=0.52,与基线无差异。
- 穿刺后6个月:效应量-0.11,p=0.18,与基线无差异。
- 经直肠穿刺3个月亚组:p=0.047,IIEF-5约降1.25分。
临床怎么用
- 穿刺前可告知患者勃起功能可能在术后1个月出现轻度下降,多数在3个月恢复。
- 对穿刺后早期出现勃起功能下降者,可随访观察,暂不必按持续性障碍处理。
- 经直肠穿刺患者3个月时若仍有下降,可结合亚组结果予以关注和评估。
局限性
- 纳入研究仅9项,样本量有限。
- 经会阴穿刺相关研究仅2项,亚组证据有限。
- 经直肠穿刺3个月结果为探索性亚组分析。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Because the association between erectile dysfunction and prostate biopsy is variable in the available literature, we sought to perform a systematic review and meta-analysis of sexual dysfunction in males within 6 months of prostate biopsy. MATERIALS AND METHODS: We conducted a systematic literature search in 4 databases: MEDLINE® (via PubMed®), Embase® (via Ovid®), Web of Science™ and the Cochrane Library. We included studies focused on sexual dysfunction in men of all age groups undergoing transrectal or transperineal prostate biopsy for suspicion of prostate cancer. We included studies with International Index of Erectile Function 5 scores pre-biopsy and post-biopsy at 1, 3 or 6 months. We performed an effect size meta-analysis comparing patient baseline International Index of Erectile Function 5 (IIEF-5) scores with post-biopsy IIEF-5 scores. RESULTS: We identified 9 studies that met our inclusion criteria, of which 6 examined transrectal prostate biopsy, 2 examined transperineal prostate biopsy and 1 examined both. At 1 month after biopsy, the mean IIEF-5 score decreased by approximately 2.2 points as determined by the effect size (-0.43, p=0.002). However, at 3 and 6 months after biopsy, there was no difference compared to baseline (effect size=-0.08, p=0.52 and effect size=-0.11, p=0.18, respectively). An exploratory subgroup analysis examining transrectal prostate biopsy at 3 months showed a statistically significantly lower mean IIEF-5 score compared to baseline (p=0.047), corresponding to an approximately 1.25-point decrease in IIEF-5. CONCLUSIONS: Prostate biopsy does cause a mild, transient decrease in average IIEF-5 scores at 1-month post-biopsy. However, this resolves at 3 months on average, and average IIEF-5 remains at baseline at 6 months post-biopsy.
引用
- Fainberg J, Gaffney CD, Pierce H, et al. Erectile Dysfunction is a Transient Complication of Prostate Biopsy: A Systematic Review and Meta-Analysis. J Urol. 2020. PMID: 33026920. doi:10.1097/JU.0000000000001398
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。